Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
Status:
Completed
Trial end date:
2002-10-18
Target enrollment:
Participant gender:
Summary
Hyperfractionated radiation therapy (RT) to 72.0 Gy with BCNU will be compared to
conventional radiation therapy to 60.0 Gy with BCNU to determine if hyperfractionated RT can
improve the median survival time of adults with supratentorial malignant gliomas.